NASDAQ:SLS   SELLAS Life Sciences Group, Inc
SLS was sold off hard the last two days despite positive news. The current price has acted as both support and resistance in recent months (shaded area).

With an RSI of 38 and the price well bellow the POC line (90 days) I think 9.08 may have been the bottom. I think the drop had more to do with large investors rebalancing for the 2nd half of the year than anything else.

I would like to see the price close above the 50SMA to enter for a long swing trade.

Targeting 12.89 in the short term.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.